Thus, it was concluded that the combination forbids gemcitabine sensitivity and induces apoptosis in pancreatic cancer cells by avoiding Notch1/PTEN, PI3K/Akt/mTOR, NF-κB pathways. This evidence concerns the gene AKT1 and pancreatic neoplasm.